Showing results (1261-1270 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|June 3, 2023
Increased risk of congenital malformations in offspring born to women with systemic lupus erythematosus in South Korea: a nationwide population-based studyYoung Mi Jung, Jin Kyun Park, Min-Jeong Oh, et al.
RMD Open|May 21, 2026
Real-world damage accrual in Sjögren's disease: a 5-year multicentre GIRRCS cohort analysisOnorina Berardicurti, Annalisa Marino, Luca Navarini, et al.
RMD Open|May 18, 2026
Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER studyNatalia Mena-Vázquez, Marta Domínguez-Álvaro, María Gema Bonilla Hernán, et al.
RMD Open|June 8, 2026
Role of the S1P/S1PR axis in inflammation and structural damage in psoriatic arthritis: a cross-sectional study with clinical, biochemical and imaging correlationDolores Ruiz-Montesinos, Dolores Mendoza-Mendoza, Jesús Bocio Núñez, et al.
RMD Open|April 10, 2026
Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE)Nora Vladimirova, Mikkel Østergaard, Sengül Seven, et al.
RMD Open|May 22, 2025
Tofacitinib monotherapy as maintenance treatment in juvenile dermatomyositis: a case reportDelia Argüelles Balas, Estefanía Barral Mena, M Ángeles Martín Díaz, et al.
RMD Open|May 29, 2025
Sacroiliac damage on MRI in axial spondyloarthritis and chronic back pain, women with postpartum back pain, runners and healthy subjectsZohra Kerami, Marleen van de Sande, Karen Minde Fagerli, et al.
RMD Open|May 29, 2025
Diagnosis of carpal tunnel syndrome with ultrasound: should we go more distal?Tomás Fontes, Alexandre Sepriano, Sofia Ramiro, et al.
RMD Open|April 29, 2026
Development and validation of a new ultrasound score (SONAR-7) for synovitis in psoriatic arthritis and axial spondyloarthritisGehad G Elsehrawy, Delphine S Courvoisier, Erik Deman, et al.
RMD Open|June 3, 2025
Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular diseaseGerd R Burmester, Eduardo Mysler, Peter Taylor, et al.
Pageof 197